Child-Physician Recommendation on Parental Adherence to Colorectal Cancer Screening
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- NYU Langone Health
- Enrollment
- 59
- Locations
- 1
- Primary Endpoint
- Change in CRC screening rate of eligible parents of internal medicine residents at NYU from before to after the intervention
Study Overview
Brief Summary
Physician recommendation has been shown to be one of the most significant predictors for colorectal cancer (CRC) screening. This study aims to identify the amount of parents of internal medicine residents at NYU who are eligible for CRC screening but have not received it. Investigators will perform an intervention and quantify the amount of parents eligible for CRC screening after the intervention. This study will entail sending 2 brief surveys (one before the intervention and one after) which determine if the parents of the residents are eligible for CRC screening. The intervention will be asking the residents with eligible parents to have a discussion with their parents about CRC screening options and to address their concerns. Investigators will provide a one page document the residents can give their parents as a reference as part of the intervention.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Screening
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Internal medicine residents at NYU - PGY1, PGY2, and PGY3 during 2017-2018 academic year
Exclusion Criteria
- Not provided
Arms & Interventions
CRC screening Survey
Residents with parents eligible for CRC screening will be asked to provide their e-mail address, solely for the use of distributing the follow up survey so it can be linked to 2 brief (3-5 min) surveys
Intervention: Survey (Other)
Outcomes
Primary Outcomes
Change in CRC screening rate of eligible parents of internal medicine residents at NYU from before to after the intervention
Time Frame: Baseline to 6 Months
Secondary Outcomes
No secondary outcomes reported